Search by Drug Name or NDC
NDC 27808-0245-01 Lacosamide 150 mg/1 Details
Lacosamide 150 mg/1
Lacosamide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Tris Pharma Inc. The primary component is LACOSAMIDE.
MedlinePlus Drug Summary
Lacosamide is used to control partial onset seizures (seizures that involve only one part of the brain) in adults and children 1 month of age and older. Lacosamide is also used in combination with other medications to control primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 4 years of age and older. Lacosamide is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 27808-0245-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lacosamide
Product Information
| NDC | 27808-0245 |
|---|---|
| Product ID | 27808-245_299cd2a3-f5a6-4e6e-8f26-84da23cff30c |
| Associated GPIs | 72600036000340 |
| GCN Sequence Number | 064434 |
| GCN Sequence Number Description | lacosamide TABLET 150 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 14341 |
| HICL Sequence Number | 035872 |
| HICL Sequence Number Description | LACOSAMIDE |
| Brand/Generic | Generic |
| Proprietary Name | Lacosamide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lacosamide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | LACOSAMIDE |
| Labeler Name | Tris Pharma Inc |
| Pharmaceutical Class | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | CV |
| Marketing Category | ANDA |
| Application Number | ANDA208308 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 27808-0245-01 (27808024501)
| NDC Package Code | 27808-245-01 |
|---|---|
| Billing NDC | 27808024501 |
| Package | 60 TABLET in 1 BOTTLE (27808-245-01) |
| Marketing Start Date | 2022-03-19 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.34946 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | LACOSAMIDE 150 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis